51 results
Page 2 of 3
8-K
EX-99.1
8z998m5xj9ty0g76a
10 Mar 22
Stoke Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
ilvj9c64
8 Nov 21
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
lyfc10k ki7l3q5
10 Aug 21
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
x404h xb4
10 May 21
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
t4yspcxp678m lda7
9 Mar 21
Stoke Therapeutics Reports Full Year 2020 Financial Results and Provides Business Updates
7:30am
8-K
EX-99.1
5fns10bgwzu4m3mze1ml
5 Feb 21
Regulation FD Disclosure
4:27pm
8-K
EX-99.1
qpy0ne4bz96i3lcq6go
11 Jan 21
Results of Operations and Financial Condition
8:01am
8-K
EX-99.1
o89 30631jmjxfypu82
20 Nov 20
Stoke Therapeutics Announces Pricing of $97.5 Million Public Offering
4:08pm
424B5
udngq7z4xiy0layqyfyr
20 Nov 20
Prospectus supplement for primary offering
4:06pm
424B5
oxi3impq4sk5 lmrs
18 Nov 20
Prospectus supplement for primary offering
4:12pm